Schizophrenia does not have a single cause. It arises from a collision of inherited genetic vulnerability and environmental exposures that unfold across a person’s development, from the womb through early adulthood. Twin studies estimate the condition’s heritability at roughly 79%, meaning genetics account for a large share of why some people develop it and others do not. But heritability is not destiny: the remaining variation comes from a web of environmental factors including prenatal infections, birth complications, childhood adversity, substance use, and social stress. Understanding how these pieces fit together is more useful than searching for a single trigger.
The Genetic Landscape
Schizophrenia runs in families, but not in a simple, predictable way. A nationwide Danish twin study estimated heritability at 79% for schizophrenia itself and about 73% when the broader spectrum of related disorders was included.1PubMed. Heritability of Schizophrenia and Schizophrenia Spectrum Based on the Nationwide Danish Twin Register That does not mean a single “schizophrenia gene” exists. Instead, the genetic risk is spread across hundreds or thousands of common gene variants, each nudging risk up by a tiny amount. Researchers bundle these into what is called a polygenic risk score. In European-ancestry samples, common variants collectively explain only about 3.5% of the variation in who actually develops the disorder.2Molecular Psychiatry. Contributions of common genetic variants to risk of schizophrenia among individuals of African and Latino ancestry That gap between 79% heritability and a few percent explained by identified variants is sometimes called the “missing heritability” problem, and it remains one of the biggest puzzles in psychiatric genetics.
Rare genetic changes also play a role. Certain deletions and duplications of chromosome segments, collectively called copy number variants, have been linked to schizophrenia. Deletions at chromosome regions 1q21.1, 15q13.3, and 22q11.2 have been consistently replicated across studies, though together they account for only about 2% of all schizophrenia cases.3PubMed Central. Copy number variations in schizophrenia: critical review and new perspectives on concepts of genetics and disease These rare variants tend to carry large individual effects and are especially associated with more developmental forms of the illness, where cognitive difficulties appear early in life.
Ancestry matters for how well genetic scores predict risk. The same polygenic scores that explain about 3.5% of variance in Europeans explain roughly 1.7% in Latino individuals and only about 0.5% in people of admixed African ancestry, largely because the original discovery studies overwhelmingly enrolled European participants.2Molecular Psychiatry. Contributions of common genetic variants to risk of schizophrenia among individuals of African and Latino ancestry Incorporating data from more diverse populations improves prediction across the board, but there is still a long way to go before genetic scores become clinically useful for any group.
What Happens Before and During Birth
Several events during pregnancy and delivery can raise the odds of schizophrenia decades later. Maternal infections during pregnancy are among the best-studied prenatal risk factors. Infections with the parasite Toxoplasma gondii have the strongest and most replicated association, but influenza, rubella, and bacterial infections during pregnancy have also been linked to increased risk in the offspring.4PubMed Central. Prenatal Infection and Schizophrenia: A Decade of Further Progress The mechanism likely involves the mother’s immune response rather than direct infection of the fetus: elevated inflammatory signaling molecules in maternal blood during pregnancy have been found in pregnancies that later gave rise to schizophrenia cases.5PubMed Central. Prenatal infection as a risk factor for schizophrenia
Complications during delivery matter, too. A longitudinal study of a national birth cohort found that preeclampsia was the strongest individual obstetric risk factor for later schizophrenia, but extreme prematurity and oxygen deprivation at birth also carried independent risks.6Archives of General Psychiatry. Obstetric Complications and the Risk of Schizophrenia: A Longitudinal Study of a National Birth Cohort A Finnish study found that oxygen-deprivation-related birth complications were specifically associated with early-onset schizophrenia rather than later-onset forms of the illness.7PubMed. Obstetric risk factors for early-onset schizophrenia in a Finnish birth cohort These findings suggest that the developing brain is especially vulnerable to insults during pregnancy and delivery, and that the damage can remain silent for years before symptoms appear.
Paternal Age
One of the more unexpected risk factors is the age of the father at conception. A large Israeli cohort study found a steady, dose-like increase in schizophrenia risk as fathers got older: offspring of men aged 50 or above had roughly three times the risk compared to offspring of men under 25.8Archives of General Psychiatry. Advancing Paternal Age and the Risk of Schizophrenia A second study put the figure at about 2.8 times the odds for fathers aged 45 and older compared to those in their early twenties.9PubMed. Paternal age and schizophrenia: further support for an association The most widely cited explanation is that sperm cells accumulate new mutations with each round of division over a man’s lifetime. The older the father, the more mutations his sperm carry, and some of those mutations may land in genes relevant to brain development. This has been reviewed extensively, and while the association is well-established across multiple cohorts, the precise biological pathway is still being worked out.10PubMed Central. Advanced paternal age and risk of schizophrenia in offspring – Review of epidemiological findings and potential mechanisms
Childhood Adversity and Social Stress
What happens after birth can be just as important as what happens before it. Childhood trauma, including physical abuse, emotional abuse, sexual abuse, and neglect, is significantly more common in people who later develop schizophrenia than in the general population.11Schizophrenia. Linking childhood trauma to the psychopathology of schizophrenia: the role of oxytocin Large cross-sectional surveys have reported effect sizes ranging from about 1.7 to 15 times the risk, though the quality and design of these studies varies widely, and researchers cannot fully rule out reverse causality or shared confounders.12PubMed Central. Do Child Abuse and Maltreatment Increase Risk of Schizophrenia? One proposed framework is the neural diathesis-stress model, which suggests that severe stress early in life acts on a brain that is already genetically vulnerable and tips it past a threshold for developing psychosis.13PubMed Central. Childhood Trauma in Schizophrenia: Current Findings and Research Perspectives
Growing up in a city also raises risk. Epidemiological studies have consistently found that urban birth and urban upbringing are associated with higher rates of psychosis.14PubMed Central. Psychosis and urbanicity: a review of the recent literature from epidemiology to neurourbanism One study estimated that urban birth was associated with roughly triple the odds of first-episode schizophrenia even after adjusting for other variables.15Schizophrenia. Associations between urban birth or childhood trauma and first-episode schizophrenia mediated by low IQ Brain imaging research has found that urban upbringing correlates with reduced gray matter in the prefrontal cortex, an area critical for higher-level thinking and stress regulation.16PubMed Central. Brain structure correlates of urban upbringing, an environmental risk factor for schizophrenia What exactly about city living drives the risk is unclear, but candidates include social stress, pollution, noise, crowding, and reduced access to green space.
Migration and minority status add another layer. Immigrants, and especially their children born in the new country, face elevated rates of psychotic disorders in many study settings.17PubMed Central. Psychoses sans Frontieres: towards an interdisciplinary understanding of psychosis risk amongst migrants and their descendants The “social defeat” hypothesis ties many of these environmental threads together, proposing that the chronic experience of being excluded from a dominant social group is the common thread linking urban upbringing, migration, childhood trauma, low cognitive ability, and substance use to schizophrenia risk.18PubMed Central. The social defeat hypothesis of schizophrenia: an update The evidence is strongest for migration and childhood trauma; for the other factors the support is suggestive but not yet definitive.
Cannabis and Other Substances
Cannabis use is one of the most debated risk factors for schizophrenia. Longitudinal studies have found that regular cannabis use predicts an increased risk of both schizophrenia and psychotic symptoms, even after controlling for other drug use and personal characteristics.19PubMed Central. Cannabis use and the risk of developing a psychotic disorder A dose-response relationship has been observed: heavier use is associated with more psychotic-like experiences, and starting before age 17 amplifies the risk further.20Journal of Psychiatric Research. Dose–response effect between cannabis use and psychosis liability in a non-clinical population: Evidence from a snowball sample
Whether cannabis actually causes psychosis or simply brings it out in people who were already vulnerable is a genuinely hard question. The strongest case for a causal role comes from the dose-response pattern, the temporal ordering in longitudinal studies (cannabis use precedes symptoms), and the persistence of the association after adjusting for confounders. But it is also clear that most people who use cannabis never develop schizophrenia, which points to individual vulnerability factors, including genetics.
When Genes and Environment Collide
Some of the most illuminating research looks at how specific genes and specific exposures interact. A striking example involves the AKT1 gene and cannabis. People who carry certain variants of AKT1 and also use cannabis show impaired cognitive performance and a higher rate of psychotic-like experiences, whereas cannabis users with different variants of the same gene show no such effect.21PubMed Central. AKT1 moderation of cannabis-induced cognitive alterations in psychotic disorder This was demonstrated not only in people with existing psychotic disorders but also in otherwise healthy young cannabis smokers: the AKT1 genotype predicted who had an acute psychotic response to the drug and who did not.22PubMed Central. AKT1 genotype moderates the acute psychotomimetic effects of naturalistically smoked cannabis in young cannabis smokers Results like this show why one-size-fits-all warnings about cannabis miss the point: the same exposure can be relatively harmless to one person and devastating to another, depending on their genetic makeup.
More broadly, a systematic review of gene-environment interaction studies in schizophrenia found a wide range of findings, reflecting both the complexity of the biology and the difficulty of this kind of research.23PubMed. Molecular genetic gene-environment studies using candidate genes in schizophrenia: a systematic review Epigenetic mechanisms are one way these interactions can become durable. Early-life stress can trigger lasting changes in how genes are read by cells, particularly through chemical modifications to DNA that switch genes on or off without altering the DNA sequence itself. These changes have been found at genes important for brain development and the function of mature neurons.24PubMed Central. Epigenomics of Major Depressive Disorders and Schizophrenia: Early Life Decides One study found that siblings with childhood trauma showed altered methylation at a gene involved in the brain’s glutamate signaling system, but only in individuals who also had a liability to psychosis, not in healthy controls.25PubMed. The relationship of childhood trauma and DNA methylation of NMDA receptor genes in first-episode schizophrenia Findings like this help explain how the same traumatic experience can leave different biological fingerprints depending on a person’s underlying vulnerability.
What Changes in the Brain
Several brain chemistry systems go awry in schizophrenia, and understanding them helps explain why symptoms take the forms they do. The oldest and most established model centers on dopamine. The revised dopamine hypothesis holds that dopamine signaling is abnormally high in one set of brain pathways and abnormally low in another: excessive dopamine activity in the mesolimbic system drives hallucinations and delusions, while too little dopamine in the prefrontal cortex contributes to cognitive difficulties and motivational problems.26PubMed Central. The role of dopamine in schizophrenia from a neurobiological and evolutionary perspective: old fashioned, but still in vogue This dual imbalance is why standard antipsychotic medications, which block dopamine receptors, help with hallucinations and delusions but often do little for cognitive or motivational symptoms.
A second line of research focuses on glutamate, the brain’s main excitatory signaling molecule. Evidence from genetics, brain imaging, and pharmacology points to underactivity of a particular glutamate receptor, the NMDA receptor, in schizophrenia.27PubMed Central. The NMDA Receptor and Schizophrenia: From Pathophysiology to Treatment Drugs that block NMDA receptors can produce a remarkably complete mimic of schizophrenia symptoms in healthy people, including not just hallucinations but also the cognitive and social withdrawal symptoms that dopamine models struggle to explain.28PubMed Central. Glutamate in schizophrenia: a focused review and meta-analysis of ¹H-MRS studies The glutamate and dopamine systems are deeply interconnected, so these are probably not competing explanations but rather two views of the same cascade of dysfunction. Whether NMDA receptor underactivity is a specific mechanism that causes schizophrenia or a more general feature of the illness remains an open debate.29Translational Psychiatry. Glutamatergic dysfunction in Schizophrenia
The Immune System and Inflammation
An increasingly prominent thread in schizophrenia research involves the immune system. People with schizophrenia show abnormalities across virtually every arm of immunity, including elevated inflammation markers, dysregulated immune-signaling proteins, higher white blood cell counts, and altered gut bacteria.30PubMed Central. Immune System Abnormalities in Schizophrenia: An Integrative View and Translational Perspectives These peripheral immune changes appear to promote inflammation within the brain itself, which is in turn associated with the cognitive deficits and brain-volume reductions seen in the disorder.
The immune angle connects back to earlier risk factors. Maternal infection during pregnancy activates the mother’s immune system, and animal models show that this immune activation alone, even without the pathogen reaching the fetus, can produce brain and behavioral changes in offspring that resemble schizophrenia.31PubMed. Role of inflammation in the pathogenesis of schizophrenia: A review of the evidence, proposed mechanisms and implications for treatment The complement system, a part of innate immunity that helps clear cellular debris, also appears to be involved: overly aggressive complement-mediated pruning of synapses during adolescence has been proposed as one way genetic risk translates into the loss of brain connections seen in schizophrenia. This is still an active area of investigation, but it offers one of the more compelling bridges between genes, early-life exposures, and the brain changes that emerge years later.
Emerging research on the gut-brain axis adds another dimension. People with schizophrenia show significant differences in gut microbiome composition compared to healthy controls, and these microbial differences may influence brain function through immune signaling, the production of neurotransmitter precursors, and the generation of short-chain fatty acids.32PubMed Central. Gut Microbiome: A Brief Review on Its Role in Schizophrenia and First Episode of Psychosis Diet, medication use, stress, and environmental pollutants can all disrupt the microbiome, potentially feeding back into the neuroinflammatory processes already described.33PubMed Central. The Gut-Brain Axis in Schizophrenia: The Implications of the Gut Microbiome and SCFA Production The field is young and the findings largely correlational, but it highlights how the boundary between “brain disorder” and “whole-body disorder” is increasingly blurred.
Somatic Mutations in the Brain
Most discussions of schizophrenia genetics focus on inherited variants, the DNA you get from your parents. But a newer line of research looks at mutations that arise after conception, during fetal brain development. Deep whole-genome sequencing of brain neurons from people with schizophrenia has found an excess of somatic mutations in regions of the genome that regulate gene activity, including at the binding sites of proteins that control when and where genes are turned on.34PubMed Central. Somatic mosaicism in schizophrenia brains reveals prenatal mutational processes Some of these mutations affect known schizophrenia risk genes and genes involved in neurodevelopment, and they appear to arise during the rapid cell division of early brain formation. These findings mean that two people with identical inherited genomes could still differ in schizophrenia risk because of random errors that occurred during fetal development.35PubMed. Low-Level Brain Somatic Mutations Are Implicated in Schizophrenia The research is still preliminary, but it adds a layer of biological randomness to an already complex picture.
Recognizing the Prodrome
Schizophrenia rarely arrives out of nowhere. Most people experience a prodromal phase of months or years before full-blown psychosis, with symptoms like social withdrawal, difficulty concentrating, unusual perceptual experiences, and vague suspiciousness. Identifying people in this high-risk state has been a major goal of early-intervention research. A meta-analysis of studies using clinical high-risk criteria found that about 22% of high-risk individuals transitioned to a full psychotic episode within two years, rising to about 36% with longer follow-up.36JAMA Psychiatry. Predicting Psychosis: Meta-analysis of Transition Outcomes in Individuals at High Clinical Risk The type of high-risk symptoms also matters: people experiencing brief, self-resolving psychotic episodes had the highest short-term transition rate, while those identified only by a family history of psychosis combined with a recent decline in functioning had the lowest.37PubMed. Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis?
These numbers also mean that a majority of people identified as clinically high risk do not develop psychosis. Some recover completely, and others develop mood or anxiety disorders instead. That uncertainty makes intervention tricky: offering treatments with significant side effects to someone who has a roughly one-in-four chance of transitioning raises real ethical questions. Still, the prodromal window is valuable because early treatment, when psychosis does develop, is consistently associated with better long-term outcomes. Recognizing the warning signs and getting a professional evaluation matters, even if it does not lead to a schizophrenia diagnosis.
Why Schizophrenia Persists in the Population
A question that has puzzled researchers for decades is why schizophrenia, which clearly reduces reproductive fitness, has not been selected out of the human gene pool. The disorder occurs at roughly 1% prevalence across cultures, and people with schizophrenia have fewer children on average, especially men.38PubMed. The evolutionary paradox and the missing heritability of schizophrenia A large Icelandic genomic study found no evidence that carrying a high genetic burden for schizophrenia confers a reproductive advantage in the general, unaffected population, which rules out one popular theory.39Nature Communications. Reproductive fitness and genetic risk of psychiatric disorders in the general population
A more recent model, the “cliff edge” hypothesis, offers a compelling alternative. It proposes that the same genetic variants that contribute to schizophrenia at high doses may, at lower doses, enhance traits like language ability, creativity, or social cognition that are beneficial for survival and reproduction. Most people carrying some of these variants fall within a normal, advantageous range. Only beyond a certain genetic threshold do the traits tip into the disorganized thinking and perceptual disturbances of schizophrenia, a sharp drop-off in function resembling a cliff edge.40PubMed. The cliff edge model of the evolution of schizophrenia: Mathematical, epidemiological, and genetic evidence This model aligns with the polygenic architecture of the illness: because risk is spread across so many variants, most people inherit some without exceeding the threshold, and natural selection never has a clean target to eliminate.
Polygenic Risk and Treatment Response
One practical implication of the genetic research, still in early stages, is whether a person’s genetic risk score might predict how well they respond to treatment. Across four cohorts of patients experiencing their first psychotic episode, higher polygenic risk scores were associated with poorer symptom improvement after twelve weeks of antipsychotic medication. Patients with a low genetic burden were roughly twice as likely to respond to treatment as those with a high burden.41PubMed Central. Schizophrenia Polygenic Risk Score as a Predictor of Antipsychotic Efficacy in First Episode Psychosis The effect was modest, explaining only a few percent of variation in outcomes, and is nowhere near ready for clinical use. But it offers a glimpse of a future where genetic information might help guide treatment decisions, identifying patients who need more intensive or alternative approaches from the start rather than through months of trial and error.